Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Thoracic and Cardiovascular Surgery

• Publication date

  2005-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JTCVS.2004.12.048PMID 15942563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prosthetic aortic valve replacement.

  2005cited by this paper
• Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis

  2004cited by this paper
• Lung cancer and cyclooxygenase-2.

  2003cited by this paper
• Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma.

  2003cited by this paper
• Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

  2003cited by this paper
• Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer.

  2002cited by this paper
• Celecoxib reduces pulmonary inflammation but not lung tumorigenesis in mice.

  2002cited by this paper
• Aspirin and lung cancer in women

  2002cited by this paper
• Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44*

  2001cited by this paper
• Meloxicam inhibits the growth of non-small cell lung cancer.

  2000cited by this paper
• Host cyclooxygenase-2 modulates carcinoma growth.

  2000cited by this paper
• Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models.

  2000cited by this paper
• Non-steroidal anti-inflammatory drugs and bladder cancer prevention

  2000cited by this paper
• Expression of cyclooxygenase‐2 in prostate carcinoma

  2000cited by this paper
• Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

  2000cited by this paper
• Inhibition of COX-2 and induction of apoptosis: two determinants of nonsteroidal anti-inflammatory drugs' chemopreventive efficacies in mouse lung tumorigenesis.

  2000cited by this paper
• Indomethacin Inhibits the Accumulation of Tumor Cells in Mouse Lungs and Subsequent Growth of Lung Metastases

  2000cited by this paper
• Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

  2000cited by this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Celecoxib

  2000cited by this paper
• COX‐2 is expressed in human pulmonary, colonic, and mammary tumors

  2000cited by this paper
• Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398.

  1998cited by this paper
• Cyclooxygenase in biology and disease

  1998cited by this paper
• Cyclooxygenase regulates angiogenesis induced by colon cancer cells.

  1998cited by this paper
• Cyclooxygenases 1 and 2.

  1998cited by this paper
• Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.

  1997cited by this paper
• Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice.

  1997cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study

  1994cited by this paper
• Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals

  1994cited by this paper
• Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group.

  1993cited by this paper
• Aspirin use and risk of fatal cancer.

  1993cited by this paper
• Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line.

  1992cited by this paper
• Primary response genes induced by growth factors and tumor promoters.

  1991cited by this paper

• The MYC/TXNIP axis mediates NCL-Suppressed CD8+T cell immune response in lung adenocarcinoma

  2025cites this paper
• Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection

  2020cites this paper
• Cell adhesion molecule control of planar spindle orientation

  2016cites this paper
• Combined zoledronic acid and meloxicam reduced bone loss and tumour growth in an orthotopic mouse model of bone-invasive oral squamous cell carcinoma.

  2015cites this paper
• Synthesis, biological activity screening and molecular modeling study of acylaminoacetamide derivatives

  2015cites this paper
• CHAPTER 5 CELECOXIB ENHANCES THE RADIORESPONSE OF SECONDARY BONE TUMORS OF A HUMAN NON-SMALL CELL LUNG CANCER VIA ANTI-ANGIOGENESIS IN VIVO

  2011cites this paper
• Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting.

  2010cites this paper
• Celecoxib Enhances Radiation Response of Secondary Bone Tumors of a Human Non-Small Cell Lung Cancer via Antiangiogenesis In Vivo

  2010cites this paper
• Die antioxidative Wirkung von Cyclooxygenase-2-Hemmern gemessen an Miniorgankulturen nasaler Schleimhaut

  2009influential citation
• Cyclooxygenase-2 (COX-2) Inhibitors Reduce Immune Tolerance through Indoleamine 2,3-dioxygenase (IDO).

  2007cites this paper
• Cyclooxygenase inhibitors not inhibit resting lung cancer A549 cell proliferation.

  2006cites this paper
• 9-cis-Retinoic acid inhibition of lung carcinogenesis in the A/J mouse model is accompanied by increased expression of RAR-beta but no change in cyclooxygenase-2.

  2006cites this paper
• Association between cyclooxygenase and epidermal growth factor receptor pathways in non-small cell lung cancer.

  2005cites this paper